TORLEY HELEN (PRESIDENT AND CEO) sold 6.1% of their position (50K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.37M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+20K
Price / share
$12.07
Trade value
$241.40K
% of position
Common Stock
Shares
−1.61K
Price / share
$66.39
Trade value
$106.88K
% of position
Common Stock
Shares
−12.99K
Price / share
$67.41
Trade value
$875.59K
% of position
Common Stock
Shares
−5.40K
Price / share
$68.35
Trade value
$369.14K
% of position
Common Stock
Shares
+20K
Price / share
$12.07
Trade value
$241.40K
% of position
Common Stock
Shares
−16.60K
Price / share
$66.31
Trade value
$1.10M
% of position
Common Stock
Shares
−3.40K
Price / share
$66.75
Trade value
$226.93K
% of position
Common Stock
Shares
+10K
Price / share
$12.07
Trade value
$120.70K
% of position
Common Stock
Shares
−400.00
Price / share
$66.37
Trade value
$26.55K
% of position
Common Stock
Shares
−1.50K
Price / share
$67.67
Trade value
$101.51K
% of position
Common Stock
Shares
−2K
Price / share
$68.74
Trade value
$137.47K
% of position
Common Stock
Shares
−6.10K
Price / share
$69.69
Trade value
$425.12K
% of position
Net shares
+0.00
Net value
-$2.77M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | M · Option Exercise | +20K | $12.07 | $241.40K | 2.6% | 767.78K | 787.78K |
| Common Stock Direct | 6/1/2026 | S · Sale | −1.61K | $66.39 | $106.88K | 0.2% | 787.78K | 786.17K |
| Common Stock Direct | 6/1/2026 | S · Sale | −12.99K | $67.41 | $875.59K | 1.7% | 786.17K | 773.18K |
| Common Stock Direct | 6/1/2026 | S · Sale | −5.40K | $68.35 | $369.14K | 0.7% | 773.18K | 767.78K |
| Common Stock Direct | 6/2/2026 | M · Option Exercise | +20K | $12.07 | $241.40K | 2.6% | 767.78K | 787.78K |
| Common Stock Direct | 6/2/2026 | S · Sale | −16.60K | $66.31 | $1.10M | 2.1% | 787.78K | 771.18K |
| Common Stock Direct | 6/2/2026 | S · Sale | −3.40K | $66.75 | $226.93K | 0.4% | 771.18K | 767.78K |
| Common Stock Direct | 6/3/2026 | M · Option Exercise | +10K | $12.07 | $120.70K | 1.3% | 767.78K | 777.78K |
| Common Stock Direct | 6/3/2026 | S · Sale | −400.00 | $66.37 | $26.55K | 0.1% | 777.78K | 777.38K |
| Common Stock Direct | 6/3/2026 | S · Sale | −1.50K | $67.67 | $101.51K | 0.2% | 777.38K | 775.88K |
| Common Stock Direct | 6/3/2026 | S · Sale | −2K | $68.74 | $137.47K | 0.3% | 775.88K | 773.88K |
| Common Stock Direct | 6/3/2026 | S · Sale | −6.10K | $69.69 | $425.12K | 0.8% | 773.88K | 767.78K |
| Total | +0.00 | -$2.77M | ||||||
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
12.07
Held after
31.92K
Exercisable
—
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
12.07
Held after
11.92K
Exercisable
—
Option to Purchase Common Stock
Common Stock
10K shares
Shares
−10K
Strike price
12.07
Held after
1.92K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock20K shares | 6/1/2026 | M · Option Exercise | −20K | 12.07 | — | 31.92K |
| Option to Purchase Common Stock Direct | Common Stock20K shares | 6/2/2026 | M · Option Exercise | −20K | 12.07 | — | 11.92K |
| Option to Purchase Common Stock Direct | Common Stock10K shares | 6/3/2026 | M · Option Exercise | −10K | 12.07 | — | 1.92K |